UK Markets open in 7 hrs 12 mins

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
53.42-5.01 (-8.57%)
At close: 04:00PM EDT
53.78 +0.36 (+0.67%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close58.43
Bid53.51 x 1800
Ask53.80 x 900
Day's range48.75 - 56.91
52-week range41.33 - 277.80
Avg. volume4,696,274
Market cap4.039B
Beta (5Y monthly)1.33
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Better Buy: Moderna or Novavax?

    Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) are no longer big winners for investors. Let's first address the uncertainties for Moderna. There are questions about the high number of side effects of its experimental influenza vaccine.

  • Motley Fool

    Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding

    Shares of Pfizer (NYSE: PFE) were up 2.5% as of 11:35 a.m. ET on Friday after jumping as much as 4% earlier in the day. Meanwhile, the stocks of two other COVID-19 vaccine makers were declining. Moderna's (NASDAQ: MRNA) shares were down 4.7%.

  • Motley Fool

    Will Novavax Stock Ever Reach Its All-Time High Again?

    Novavax (NASDAQ: NVAX) investors are no strangers to tragedy. On Feb. 9 in 2021, shares of the coronavirus vaccine developer hit their all-time high of $331.68. Are longtime shareholders doomed to heavy losses forever, or will Novavax return to its glory days?